TB Alliance Names Angela Vanderploeg as Chief Financial Officer

NEW YORK, July 13, 2018 /PRNewswire-USNewswire/ -- TB Alliance today announced the appointment of Angela Vanderploeg as Chief Financial Officer. Ms. Vanderploeg joins TB Alliance most recently from New Leaders, an educational nonprofit, where she helped re-establish and grow the financial strength of the organization, driving gains in the organization's productivity.

In this new role, Ms. Vanderploeg will oversee all aspects of financial management for the TB Alliance in the pursuit of new and improved therapies for tuberculosis ? the deadliest infectious disease in the world. As a not-for-profit, product development partnership, TB Alliance must manage an operating budget for activities traditionally associated with the discovery, development and delivery of novel pharmaceutical products while ensuring both short- and long-term financial sustainability. In addition, Ms. Vanderploeg will help build and maintain relationships with a variety of donors and partners around the world.

"I'm eager to apply my skills and experience to help enable an organization at the forefront of combating one of humanity's oldest, most persistent, and deadliest global health threats," said Ms. Vanderploeg.

Ms. Vanderploeg has spent the previous 25 years managing the finances of both small and large organizations, including non-profits, philanthropies, social service organizations, and in the financial services industry. Having led the implementation of systems and having grown the financial health of such organizations, Ms. Vanderploeg's experiences will be invaluable to TB Alliance as it moves closer to delivering new treatments for both drug-resistant and drug-sensitive tuberculosis.

"Investment in TB research and development has traditionally been meager in comparison to what it will take to end TB. Therefore, sound financial management and appropriate stewardship of the resources provided to organizations like TB Alliance are integral to our success," said Dr. Mel Spigelman, President and CEO of the TB Alliance. "We are excited for Ms. Vanderploeg to join the organization and help achieve our mission of transforming TB treatment for the millions who suffer each year."

Ms. Vanderploeg holds an MBA from New York University. She is also a CPA and spent several years at professional accounting firms earlier in her career.

About TB Alliance

TB Alliance is a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis (TB). Through innovative science and with partners around the globe, we aim to ensure equitable access to faster, better TB cures that will advance global health and prosperity. TB Alliance operates with support from Australia's Department of Foreign Affairs and Trade, Bill & Melinda Gates Foundation, Germany's Federal Ministry of Education and Research through KfW, Global Health Innovative Technology Fund, Irish Aid, Indonesia Health Fund, National Institute of Allergy and Infectious Disease, Netherlands Ministry of Foreign Affairs, United Kingdom Department for International Development, United States Agency for International Development, and the United States Food and Drug Administration.

For more information contact:
Thomas Lynch +1 (646) 616-8639 / [email protected]

SOURCE TB Alliance